Phase 3 Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 years or older at the time of signing consent forms.
- People who are willing and able to attend all scheduled visits, follow study procedures, and complete required tests and treatments.
- People who have been diagnosed through tissue testing with primary epithelial invasive ovarian cancer of any grade, including specific types such as serous, mucinous, endometrioid, clear cell, transitional, squamous, or carcinosarcoma, at FIGO stage IC through IV.
- People who have at least one measurable area of cancer that is 10mm or larger, confirmed by a recent scan taken before the study start date.
- People whose general health and physical functioning meet a certain level (ECOG score of 2 or below) and whose life expectancy is more than 6 months.
- People who have received no more than two courses (lines) of chemotherapy treatment overall.
- People who are currently on, or have a history of, cancer treatments including chemotherapy, surgery, radiation, PARP inhibitors, biologic therapies, or hormonal treatments.
- People who are receiving treatment before surgery (neoadjuvant), after surgery (adjuvant), or for advanced cancer.
- People who are having upfront surgery, interval surgery, or a second debulking surgery as part of their cancer care.
- People who are able to understand and sign an informed consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who would not agree to receiving iron given through a drip (IV) or a blood transfusion, for example due to religious beliefs such as Jehovah's Witnesses.
- People who have had a serious allergic reaction to IV iron products in the past.
- People who have a medical condition that makes IV iron or blood transfusions unsafe, such as iron overload, a condition called hemosiderosis, severe liver cirrhosis, or active hepatitis.
- People whose life expectancy is 6 months or less (palliative patients).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If this is close to home
This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.
- Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
- Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
- Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
- Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
- Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14
Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.
Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Principal Investigator: Maryam Al-Hayki, University of Saskatchewan
Phone: 306 766 2213
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maintenance of Hgb>100g/L (Hemoglobin); Safety of IV iron; Efficiency of IV iron; Time to response; Delay In Chemotherapy; Change in QOL (quality of Life)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.